Strong Q4 with 76.0 MSEK in revenue, up 135% from Q4 2024. Submission of Biologics License Application (BLA) for imlifidase for highly sensitized patients awaiting ...
Hansa Biopharma AB, "Hansa" , today announced its Q4 2025 and full-year financial results. Renée Aguiar-Lucander, CEO, Hansa Biopharma, said, "Q4 capped a strong year for Hansa Biopharma. Filing our ...
Copilot works best with a photo upload, while ChatGPT improves through edits; get a caricature that fits your style fast.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results